Precapillary pulmonary hypertension of uncertain aetiology;Prakapillare pulmonale hypertonie unklarer genese

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 28-29, 1998, Pages 861-865

  Halank, M ^a   Wiemer, M ^a   Tschope C ^a   Poller, W ^a   Schwimmbeck, P ^a   Horstkotte, D ^a   Hoffken G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; NITRIC OXIDE; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ADULT; ANKLE EDEMA; ARTICLE; CASE REPORT; DYSPNEA; HEART RIGHT VENTRICLE FAILURE; HEPATOMEGALY; HUMAN; IDIOPATHIC DISEASE; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; ORAL DRUG ADMINISTRATION; PULMONARY HYPERTENSION; SYSTOLIC HEART MURMUR; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FUNCTION; LUNG WEDGE PRESSURE; VASCULAR RESISTANCE;

ADULT; CALCIUM CHANNEL BLOCKERS; DIAGNOSIS, DIFFERENTIAL; DILTIAZEM; DYSPNEA; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE; PULMONARY WEDGE PRESSURE; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0032503935     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024078     Document Type: Article

References (16)

1. Abenhaim, L., Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higenbottam, C. Oakley, E. Wouters, M. Aubier, G. Simonneau, B. Begaud: Appetite-suppressant drugs and the risk of pulmonary hypertension. New Engl. J. Med. 335 (1996), 609-616.
2. D'Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, J. T. Kernis, P. S. Levy, G. G. Pietra, L. M. Reid, J. T. Reeves, S. Rich, C. E. Vreim, G. W. Williams, M. Wu: Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Ann. int. Med. 115 (1991), 343-349.
3. Barst, R. J.: Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (editorial). Heart 77 (1997), 299-301.
4. Edward, B. S., E. K. Weir, W. D. Edwards, J. Ludwig, R. K. Dyskoski, J. E. Edwards: Coexistent pulmonary and portal hypertension. Morphologic and clinical features. J. Amer. Coll. Cardiol. 10 (1987), 1233-1238.
5. Jolliet, P., P. Bulpa, J.-B. Thorens, M. Ritz, J.-C. Chevrolet: Nitric oxide and prostacyclin as test agents of vasoactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange. Thorax 52 (1997), 369-372.
6. Olschewski, H., D. Walmrath, R. Schermuly, A. Ghofrani, F. Grimminger, W. Seeger: Aerolized prostacyclin and iloprost in severe pulmonary hypertension. Ann. intern. Med. 124 (1996), 820-824.
7. Petitpretz, P., F. Brenot, R. Azarian, F. Parent, B. Rain, P. Herve, G. Simonneau: Pulmonary hypertension in patients with human immunodeficiency virus infection: Comparison with primary pulmonary hypertension. Circulation 89 (1994), 2722-2727.
8. Rich, S., H. Bruce, H. Brundage: High dose calcium channel-blokking therapy for primary pulmonary hypertension. Evidence for long term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 76 (1987), 135-141.
9. Rich, S., D. R. Dantzker, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, S. K. Koerner, P. C. Levy, L. M. Reid, C. E. Vreim, G. W. Williams: Primary pulmonary hypertension. A national prospective study. Ann. intern. Med. 107 (1987), 216-223.
10. Rich, S., E. Kaufmann: High dose titration of calcium channel blocking agents for primary pulmonary hypertension. Guidelines for short term drug testing. J. Amer. Coll. Cardiol. 18 (1991), 1323-1327.
11. Rich, S., E. Kaufmann, P. S. Levy: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. New Engl. J. Med. 327 (1992), 76-81.
12. Rubin, L. J., J. Mendoza, M. Hood, M. Mc Goon, R. Barst, W. B. Williams, J. H. Diehl, J. Crow, W. Long: Treatment or primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann. intern. Med. 112 (1990), 485-491.
13. Rubin, L. J.: Primary pulmonary hypertension. Current concepts. New Engl. J. Med. 336 (1997), 111-117.
14. Schaiberger, P. H., T. C. Kennedy, F. C. Miller, J. Gal, T. L. Petty: Pulmonary hypertension associated with long-term inhalation of »crank« methamphetamine. Chest 104 (1993), 614-616.
15. Sitbon, O., F. Brenot, A. Denjean, A. Bergeron, F. Parent, R. Azarian, P. Herve, B. Raffestin, G. Simonneau: Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Amer. J. Respir. Crit. Care Med. 151 (1995), 384-389.
16. Zobel, G., D. Dacar, S. Rodel, I. Friehs: Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr. Res. 38 (1995), 198-204.